Navigation Links
Sonitus Medical Secures Strategic Investment and Technology Advancement Agreement From In-Q-Tel
Date:5/25/2009

In-Q-Tel Investment in Sonitus Medical Accelerates Development of Removable Device Intended To Undetectably Transmit Sound Via the Teeth

SAN MATEO, Calif., May 26 /PRNewswire/ -- Sonitus Medical, Inc., a medical device company developing the world's first non-surgical and removable hearing device to transmit sound via the teeth, today announced a strategic investment and technology advancement agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the CIA and the broader U.S. Intelligence Community.

Sonitus Medical is developing a nearly invisible In The Mouth (ITM) hearing and communication platform that relies on the principle of bone conduction to undetectably transmit sound via the teeth to the inner ear. Its SoundBite(TM) hearing system is designed to help people who are essentially deaf in one ear to rejoin the conversation of life.

"We are excited to join In-Q-Tel's notable portfolio of innovative technology companies," said Amir Abolfathi, CEO of Sonitus Medical. "This strategic partnership further legitimizes our SoundBite(TM) hearing system as a novel and non-surgical clinical treatment for patients who are essentially deaf in one ear. The investment by In-Q-Tel also allows us to take the logical next step toward developing our platform technology for a number of other non-medical communication applications."

"Sonitus Medical's technology capability is an important addition to our strategic investment portfolio," said Troy M. Pearsall, Executive Vice President of Architecture and Engineering at In-Q-Tel. "The advanced technology inside this removable, comfortable to wear, and discrete device employs the well understood principle of bone conduction in a unique form factor. We are also excited by the company's product roadmap, as it offers great promise for both the private and public sectors."

The In-Q-Tel investment follows an earlier funding round in 2008 led by Aberdare Ventures and Novartis Venture Funds, and a previous round led by RWI Ventures.

About In-Q-Tel:

In-Q-Tel is the not-for-profit, strategic investment firm that works to identify, adapt, and deliver innovative technology solutions to support the mission of the U.S. Intelligence Community. Launched by the CIA in 1999 as a private, independent organization, In-Q-Tel's mission is to identify and partner with companies developing cutting-edge technologies that serve the national security interests of the United States. Working from an evolving strategic blueprint defining the Intelligence Community's critical technology needs, In-Q-Tel engages with entrepreneurs, growth companies, researchers, and investors to deliver technologies that provide superior capabilities for the CIA and the larger Intelligence Community. In-Q-Tel concentrates on several broad commercial technology areas, including applications software and analytics; bio, chemical, and nanotechnology; communications and infrastructure; digital identity and security; and embedded systems and power. To date, In-Q-Tel has engaged with more than 140 companies and delivered more than 140 technology solutions to the Intelligence Community. To learn more about In-Q-Tel, visit www.iqt.org.

About Sonitus Medical:

Sonitus Medical Inc. is a privately held medical device company developing the SoundBite(TM) hearing system, a non-surgical and removable hearing solution that imperceptibly transmits sound via the teeth. Relying on the principle of bone conduction, this nearly invisible in the mouth (ITM) hearing & communication platform is initially intended as a simple and non-invasive treatment for hearing disorders such as single sided deafness and tinnitus. Potential future applications include consumer and covert communications. Founded in June 2006, Sonitus Medical is headquartered in San Mateo, California. To learn more about Sonitus Medical, please visit www.sonitusmedical.com.

About SoundBite(TM):

SoundBite(TM) hearing system is the world's first and only non-surgical and removable hearing solution that imperceptibly transmits sound via the teeth to help people who are essentially deaf in one ear to rejoin the conversation of life. A nearly invisible digital audio device, SoundBite(TM) relies on a well-established principle called bone conduction to deliver clear, high quality sound, and is intended to restore normal hearing to people with either single sided deafness, conductive, or mixed hearing loss. The SoundBite(TM) system consists of an easy to insert and remove dental retainer-like device which requires no modifications to your teeth, and a small microphone unit worn behind the ear. This device is for investigational use only and is currently undergoing clinical trials that are intended to support an initial filing for FDA 510(k) clearance for single sided deafness.


'/>"/>
SOURCE Sonitus Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
2. Photos: The Nations Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research
3. National Medical Interpreter Certification Testing Enters Pilot Phase
4. MedicalCharting.com Launches EMR Softwaret Solution with CCHIT-Certified EHR Software
5. Doctors Medical Center Election Tainted
6. Ultrasound more cost efficient than other medical imaging choices
7. Response Biomedical Closes $12.65 million Unit Offering
8. The Oro Organization, LLC Partners with Medical Hair Restoration to Launch New Website USHairReplacement.com
9. Reed Group Launches New MDGuidelines Web Site with 6th Edition of Medical Disability Advisor
10. Limiting Work Hours for Medical Residents Could Be Costly
11. Orasi Medical Wins Red Herring 100 North America Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... Pediatric ... to improve care by making data on heart procedures public and easily understandable ... Transparency and Public Reporting of Pediatric and Congenital Heart Disease Outcomes will bring ...
(Date:2/11/2016)... Washington, DC (PRWEB) , ... February 11, 2016 ... ... announce an upcoming Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study ... a not-for-profit Catholic health care system that’s partnering with Intel on value-based health ...
(Date:2/11/2016)... ISLAND, Australia (PRWEB) , ... February 11, 2016 ... ... full potential ?" motivational speaker, trainer and author Ray Clarke poses a question ... personal fulfillment . In his book, "Being in the Being" (published by ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... of a master charity program created to assist the people of their local ... closely with nonprofit organizations and community leaders. Their hope is to bring awareness ...
(Date:2/11/2016)... ... February 11, 2016 , ... Talix ... Family Practice , will be presenting at the 2016 HIMSS Annual Conference & ... , During his session, “ Coding for Care: Using Data Analytics for ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... -- The primary goal of this research is to ... usage of liquid biopsy. Key information the survey seeks ... of liquid biopsy adoption amidst future users - Predominantly ... - Sample inflow to conduct liquid biopsy tests - ... so on. - Correlation analysis of sample type and ...
(Date:2/11/2016)... Feb. 11, 2016  Walgreens has committed to provide ... and Washington, D.C. as part of ... was commended by shareholder advocacy organization As You Sow. ... Sow. "Many people hold on to unneeded drugs because they ... tragic consequences." --> Conrad MacKerron , Senior ...
(Date:2/11/2016)...  MiMedx Group, Inc. (NASDAQ: MDXG ), the ... other birth tissues, human skin and bone, and patent-protected ... products and therapies, announced today that it will present ... in New York , NY.  Parker ... Senken , Chief Financial Officer and Chris Cashman ...
Breaking Medicine Technology: